Picture of HealthEquity logo

HQY — HealthEquity News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedLarge CapHigh Flyer

HealthEquity Q2 revenue beats on HSA account growth

HealthEquity Q2 revenue beats on HSA account growth


Overview

  • U.S. HSA custodian's Q2 revenue rose 8%, slightly beating analyst expectations

  • Adjusted EPS for Q2 beat analyst expectations

  • Company repurchased $108.1 mln in stock during the quarter


Outlook

  • Healthequity raises fiscal 2027 revenue guidance to $1.411 bln-$1.421 bln

  • Company expects fiscal 2027 net income of $242 mln-$248 mln, or $2.88-$2.96 per share

  • Healthequity sees fiscal 2027 Adjusted EBITDA of $628 mln-$636 mln


Result Drivers

  • HSA ACCOUNT GROWTH - Total HSA accounts rose 8% year over year to 10.7 mln, with new HSAs from sales up 24%

  • HSA ASSET INCREASE - Total HSA assets grew 14% to $37.9 bln, driven by higher HSA investments and cash balances

  • TECHNOLOGY-ENABLED EFFICIENCY - Co said improved technology and operational efficiency contributed to results, per CEO Scott Cutler


Company press release: ID:nGNX5BCXQJ


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Slight Beat*

$350.73 mln

$349.25 mln (14 Analysts)

Q2 Adjusted EPS

Beat

$1.24

$1.19 (14 Analysts)

Q2 EPS

$0.78

Q2 Net Income

Miss

$65.64 mln

$102.009 mln (11 Analysts)

Q2 Adjusted EBITDA

Beat

$167 mln

$160.15 mln (14 Analysts)

Q2 Pretax Profit

Miss

$87.87 mln

$127.89 mln (8 Analysts)

Q2 Gross Profit

$257.95 mln

Q2 Operating Expenses

$159.26 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the software peer group is "buy"

  • Wall Street's median 12-month price target for HealthEquity, Inc. is $115.00, about 10.1% above its August 26 closing price of $104.42

  • The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 17 three months ago


Reuters Recommended Reads

  • Aug 25 - Insurance distributor SelectQuote's Q4 revenue falls 7%, misses analyst estimates

  • Aug 25 - More US employers to drop weight-loss drugs in 2027, as healthcare costs increase

  • Aug 26 - 11% of US insurance companies plan headcount cuts: Jacobson-Aon study


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on HealthEquity

See all news